These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 844618)

  • 1. Intrauterine contraception in diabetic women.
    Wiese J
    Fertil Steril; 1977 Apr; 28(4):422-5. PubMed ID: 844618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences with Antigon-F for intrauterine contraception].
    Cederqvist LL; Lauersen NH; Fuchs F
    Ugeskr Laeger; 1979 Sep; 141(37):2521-4. PubMed ID: 483438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate post-partum insertion of the Antigon.
    Wiese J; Osler M
    Acta Obstet Gynecol Scand; 1977; 56(5):509-13. PubMed ID: 602724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three intrauterine contraceptive devices: the Antigon-F, the Ypsilon-Y, and the Copper-T 200.
    Lauersen N; Cederqvist L; Donovan S; Fuchs F
    Fertil Steril; 1975 Jul; 26(7):638-48. PubMed ID: 1149898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness, safety, and acceptability of a copper intrauterine device (CU Safe 300) in type I diabetic women.
    Kimmerle R; Weiss R; Berger M; Kurz KH
    Diabetes Care; 1993 Sep; 16(9):1227-30. PubMed ID: 8404424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraception with intrauterine devices.
    Parr EL
    Bioscience; 1973 May; 23(5):281-6. PubMed ID: 4803454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [For and against the IUD in diabetics].
    Serfaty D
    Contracept Fertil Sex (Paris); 1983 Dec; 11(12):1295-8. PubMed ID: 12312724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraception for the insulin-dependent diabetic woman: the view from one clinic.
    Steel JM; Duncan LJ
    Diabetes Care; 1980; 3(4):557-60. PubMed ID: 7006945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved utilization of spacing methods--intrauterine devices (IUDs) and low-dose combined oral contraceptives (OCs)--through re-orientation training for improving quality of services. Indian Council of Medical Research Task Force on IUD and Hormonal Contraceptives.
    Contraception; 1994 Sep; 50(3):215-28. PubMed ID: 7805372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Copper-silver T: The classic T resuscitated].
    Jarvela S; Allonen H
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):45-7. PubMed ID: 12341240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.